智通财经APP获悉，华安证券发布研报称，美国储能装机稳步增长，2025年有望实现52.5GWh装机。储 能是在美国电网速度慢、容量紧的前提下，少数能在1-3年时间尺度内大规模部署、既能提升数据中心 供电可靠性，又能改善电网整体韧性和经济性的核心技术路径，预计储能将成为2030年之前美国数据中 心缺电的核心解法之一。未来5年将是本轮数据中心扩张核心窗口期，数据中心缺电逻辑将持续演绎。 华安证券主要观点如下： 美国储能现状分析 美国储能装机稳步增长，2025年有望实现52.5GWh装机。美国25年1-11月实现新增大储装机 36.23GWh，除德州加州基本盘外，亚利桑那等新兴州贡献增量。 真正卡的是5年以上的并网排队+输电建设，而不是美国整体发电能力不足。能绕开大并网队列、接在 配电网或BTM的方案，才是真正有速度价值的解决方案。储能在速度+成本+战略灵活性三个维度上均 具备比较优势。 预计数据中心缺电将刺激美国2027年储能装机超110GWh。未来5年将是本轮数据中心扩张核心窗口 期，数据中心缺电逻辑将持续演绎。在所有可行方案中，储能是少数能同时满足经济性+建设快+灵活 性高+有助于24/7 绿电的技术路径，北 ...

● 本报记者 马爽 谈及本轮市场行情的持续性及储蓄搬家情况时，唐泳表示，我国股市具备坚实的政策支撑基础，但市场 运行并非线性推进，全球外部环境变化、国内经济复苏节奏等因素仍可能引发短期波动，行情持续性面 临多重考验。此外，储蓄搬家方面则呈现出长期趋势与短期波动并存的渐进特征。 "市场波动与储蓄搬家的渐进性，恰恰凸显了券商买方投顾模式的核心价值。"唐泳表示，通过专业服务 帮助投资者穿越周期，既能助力储蓄资金平稳融入资本市场，也能推动财富管理业务高质量发展。 增量资金的持续入场，为券商行业带来了全方位的发展机遇。"资金入市不仅激活了市场流动性，更催 生了券商经纪、财富管理、投行、资管等多业务线的增长动能。"唐泳表示，经纪业务直接受益于交投 活跃度提升，业务规模显著增长；财富管理业务则在居民多元配置需求驱动下加速转型，买方投顾模式 落地进程加快。同时，市场活跃也推动了投行、资管业务的协同发展。 在唐泳看来，这不仅是行业短期业绩的增长红利，更是高质量发展的战略契机。在此背景下，券商需把 握三大发展方向的机遇：即夯实经纪业务基础，承接市场扩容带来的规模增量；加速财富管理转型，以 买方投顾服务挖掘长期价值；强化差异化竞争 ...

随着2024年"9·24"重磅金融政策的出台激活市场活力，A股、港股迎来增量资金注入，居民资产配置需 求加速释放，证券行业站在了财富管理与资产管理协同发展的关键节点。 华安证券 副总裁、华安资管董事长唐泳日前在接受中国证券报记者专访时表示，面对市场机遇与行业 挑战，华安证券将以财富管理、资管业务协同为核心，通过破解传统业务困局、科技赋能买方投顾转 型、多维布局业务增长路径，响应居民资产配置重构需求，为资本市场高质量发展注入持久动力。 行情有长期政策支撑 多业务发展迎机遇 2024年"9·24"重磅金融政策出台后，A股、港股市场迎来显著提振，增量资金持续流入，居民储蓄搬家 趋势逐步显现。从行情支撑因素来看，唐泳表示："'9·24'政策为股市注入强心剂，'十五五'规划建议将 科技创新与新质生产力置于核心位置，为资本市场提供了长期政策保障，有效稳固了市场热度与投资者 信心。" 谈及本轮市场行情的持续性及储蓄搬家情况时，唐泳表示，我国股市具备坚实的政策支撑基础，但市场 运行并非线性推进，全球外部环境变化、国内经济复苏节奏等因素仍可能引发短期波动，行情持续性面 临多重考验。此外，储蓄搬家方面则呈现出长期趋势与短期波动并 ...

● 本报记者 马爽 随着2024年"9·24"重磅金融政策的出台激活市场活力，A股、港股迎来增量资金注入，居民资产配置需 求加速释放，证券行业站在了财富管理与资产管理协同发展的关键节点。 华安证券副总裁、华安资管董事长唐泳日前在接受中国证券报记者专访时表示，面对市场机遇与行业挑 战，华安证券将以财富管理、资管业务协同为核心，通过破解传统业务困局、科技赋能买方投顾转型、 多维布局业务增长路径，响应居民资产配置重构需求，为资本市场高质量发展注入持久动力。 行情有长期政策支撑 多业务发展迎机遇 2024年"9·24"重磅金融政策出台后，A股、港股市场迎来显著提振，增量资金持续流入，居民储蓄搬家 趋势逐步显现。从行情支撑因素来看，唐泳表示："'9·24'政策为股市注入强心剂，'十五五'规划建议将 科技创新与新质生产力置于核心位置，为资本市场提供了长期政策保障，有效稳固了市场热度与投资者 信心。" 谈及本轮市场行情的持续性及储蓄搬家情况时，唐泳表示，我国股市具备坚实的政策支撑基础，但市场 运行并非线性推进，全球外部环境变化、国内经济复苏节奏等因素仍可能引发短期波动，行情持续性面 临多重考验。此外，储蓄搬家方面则呈现出长 ...

Group 1 - The core speculation revolves around the potential departure of Chen Qiming, a senior fund manager at Huafu Fund, following a series of announcements regarding changes in fund management [2][3] - On January 17, 2026, Huafu Fund announced changes in fund managers for several products managed by Chen Qiming, further fueling market speculation about his imminent departure [4] - Chen Qiming has been with Huafu Fund since February 2010, holding various positions, and has recently been promoted to Vice General Manager and Director of Equity Investment [4][5] Group 2 - Huafu Fund has experienced frequent personnel changes and structural adjustments since 2025, including the resignation of key executives and a shift in the board of directors [6] - The company is undergoing a dual transformation in management and ownership, with its largest shareholder, Huazhong Securities, planning to increase its stake to gain control [3][7] - As of the third quarter of 2025, Huafu Fund's total public fund size was approximately 106.21 billion yuan, with a significant portion in bond and money market funds [7] Group 3 - Chen Qiming's management performance has been notable, with returns of 47.87%, 50.30%, and 16.58% over the past one, two, and three years, respectively, significantly outperforming the CSI 300 index [5] - The recent changes in fund management, including the appointment of new co-managers, suggest a strategy for a smooth transition in investment management [4][5] - Huafu Fund's financial performance has been under pressure, with a decline in revenue and net profit in 2024 compared to the previous year [7][8]

【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 华安证券研报指出，众生药业RAY1225国内商业化合作落地，创新转型进入收获期。后续产品上 市后有权获得许可产品净销售额双位数的销售提成，国内商业化合作落地，持续关注产品后续开发。持 续关注流感创新药昂拉地韦片获批上市后逐步放量，同时，在研产品长效GLP-1RAY1225注射液在临床 Ⅱ期试验的结果，展现出了较好的疗效和安全性，国内商业化落地后，持续关注其海外权益授权，维持 此前盈利预测，维持"买入"投资评级。 （责任编辑：刘畅 ） ...

Core Insights - The report from Huazhong Securities highlights breakthroughs in small nucleic acid technology and its application in rare diseases, cardiovascular diseases, significant metabolic areas, CNS, and even oncology, indicating a growing investment opportunity in the siRNA sector [1] Group 1: Key Events - Novartis plans a major investment in small nucleic acids by 2025, with three business development (BD) transactions and a $12 billion acquisition, reflecting significant industry impact [1] - Novartis's product Inclisiran achieved $555 million in sales in the first half of 2025, a 66% year-on-year increase, and its Swiss base received an $80 million investment to expand siRNA production [1] - Domestic company Bewang Pharmaceutical's $5 billion out-licensing deal with Novartis sets a record for non-oncology BD transaction amounts [1] Group 2: Technological Advancements - Delivery technology is advancing from liver-targeting to cross-brain and lung-targeting, indicating breakthroughs in extrahepatic targeting [2] - The range of indications is expanding from rare diseases and cardiovascular conditions to significant metabolic areas, CNS, and oncology [2] Group 3: Drug Target Layout - Established targets include Inclisiran (PCSK9), which opened the siRNA application in cardiovascular fields, with emerging targets like INHBE and ALK7 showing promising initial data in obesity [3] - New targets such as ApoC3, Lpa, and ANGPTL3 are becoming standard for drug companies in lipid regulation treatments, while AGT and FXI are deepening applications in hypertension and thrombotic diseases [3] - The siRNA application scope is continuously expanding with new developments in diseases related to complement and kidney conditions [3]

Group 1 - The core viewpoint emphasizes a shift from narrative-driven trends to performance-based evaluations as the market enters the earnings forecast period, with a focus on sectors like chemicals, non-ferrous metals, and power equipment [2][5] - The adjustment of financing margin ratios is seen as a measure to stabilize the market and guide rational investment, indicating a potential shift towards a more balanced market environment [7][10] - The article highlights the acceleration of thematic rotation in the market, particularly focusing on domestic semiconductor and power sectors, driven by regulatory actions and strong demand [3][4] Group 2 - The market is expected to experience short-term fluctuations due to increased financing margin ratios and the cooling of previously hot themes, with a focus on sectors that show strong demand and industrial catalysts [4][8] - There is a recommendation for investors to adopt a cautious approach, focusing on sectors that benefit from structural changes and performance improvements, such as new energy and consumer goods [6][12] - The AI industry chain is identified as a key area for investment, with a consensus forming around its growth potential, despite some volatility in related sectors [13]

Group 1 - The market is expected to experience a shift from a one-sided trend driven by narratives and capital to a more performance-focused environment as annual report forecasts approach [2][4] - The adjustment of financing margin ratios is seen as a signal to guide rational investment and maintain market stability, with a focus on sectors like traditional manufacturing and resource pricing [2][5] - The recent regulatory measures aim to prevent excessive speculation and market manipulation, leading to a more rational return of market sentiment [3][4] Group 2 - The focus is shifting towards sectors with strong demand support and industrial catalysts, particularly in low-position technology areas such as domestic computing power and new energy [3][4] - The upcoming earnings disclosures are expected to heighten the competitive sentiment around performance, with attention on sectors that may exceed expectations [4][9] - The market is likely to transition into a consolidation phase after reaching previous highs, with a recommendation for investors to adopt a stable allocation strategy [5][7] Group 3 - The "spring market" is facing short-term pressures due to various factors, including complex overseas macro environments and domestic regulatory intentions [6][8] - Despite recent market weaknesses, there is potential for continued upward movement in the AI application sector, driven by strong fundamentals [6][11] - The overall market valuation remains reasonable, supported by macro policies and a gradual recovery in corporate earnings [9][10]

Core Viewpoint - The recent release of the Shanghai Stock Exchange's guidelines for bond trustee management marks a significant shift from passive compliance oversight to proactive credit management, enhancing the professional standards for trustees and creating new competitive opportunities for brokers, especially smaller firms [2][3]. Group 1: Changes in Trustee Management - The traditional trustee management model, which focused on post-event compliance and risk management, is becoming inadequate due to the increasing complexity of issuer risk characteristics and transmission paths [3]. - The new guidelines emphasize the need for trustees to engage in proactive credit management throughout the bond lifecycle, including continuous monitoring of issuer credit characteristics and early intervention in risk situations [3][4]. - The shift in focus from compliance to active value management requires trustees to assist issuers in credit maintenance and enhance communication with investors, moving towards differentiated service models [4]. Group 2: Challenges in Implementation - Despite the positive direction of the new guidelines, there are significant challenges in implementing proactive credit management, particularly for smaller brokers [5]. - Active credit management requires substantial long-term investment in human resources and expertise, which may not yield immediate returns compared to traditional underwriting revenues [5]. - The need for cross-departmental collaboration and integration of resources poses additional challenges, especially for smaller firms with limited departmental structures [5][6]. Group 3: Opportunities for Smaller Brokers - While proactive credit management presents higher immediate demands, it also offers smaller brokers a chance to differentiate themselves by leveraging their agility and closer relationships with issuers [6]. - The evolving competitive landscape is pushing brokers to extend their core competencies beyond underwriting to include value creation and risk management throughout the bond lifecycle [6]. - Smaller firms can capitalize on their shorter decision-making chains and faster response times to establish deeper trust with issuers in the niche of bond lifecycle management [6]. Group 4: Required Core Competencies - Brokers need to enhance several core competencies to succeed in the new environment, including professional research capabilities to improve risk identification and warning systems [6][7]. - Data analysis capabilities must be developed to utilize technologies like big data and AI for real-time monitoring and dynamic assessment of issuer credit status [6][7]. - Strengthening communication and coordination skills with issuers, investors, and regulatory bodies is essential for timely information dissemination and conflict resolution [6][7]. - Innovation in service offerings and compliance management capabilities is also critical to meet diverse market demands and ensure legal compliance in credit management activities [7].